Home > Balance Sheet > NGL FINECHEM

NGL FINECHEM
Total Non-Current Liabilities

    Back to Balance Sheet
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹69 Cr₹41 Cr₹6.32 Cr₹6.24 Cr₹8.06 Cr

What is the latest Total Non-Current Liabilities ratio of NGL FINECHEM ?

The latest Total Non-Current Liabilities ratio of NGL FINECHEM is ₹69 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹69 Cr
Mar2025₹41 Cr
Mar2024₹6.32 Cr
Mar2023₹6.24 Cr
Mar2022₹8.06 Cr

How is Total Non-Current Liabilities of NGL FINECHEM Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹69 Cr
67.27
Mar2025 ₹41 Cr
549.52
Mar2024 ₹6.32 Cr
1.27
Mar2023 ₹6.24 Cr
-22.60
Mar2022 ₹8.06 Cr -

Compare Total Non-Current Liabilities of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,628.3 Cr -8.5% -5.5% 84% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -0.2% -4.9% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,904.0 Cr 1.3% -2.3% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹172,213.0 Cr -1.5% -5.8% 29.3% Stock Analytics
CIPLA ₹106,138.0 Cr 0.1% -4.2% -14.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,304.0 Cr 1.9% 5.7% 0.4% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-8.5%

-5.5%

84%

SENSEX

0.9%

-0.8%

-10.5%


You may also like the below Video Courses